Design, synthesis and biological evaluation of phosphoroxy quinazoline derivatives as potential EGFRT790M/C797S inhibitors
Bioorganic & Medicinal Chemistry(2023)
摘要
Brigatinib was used as the lead compound to modify its structure to obtain a series of derivatives with a skeleton of phosphoroxy quinazoline. Among them, compound 8a showed excellent inhibitory activity against C797S mutant EGFR enzyme and cancer cells. Significantly, 8a presented acceptable pharmacokinetic parameters and exhibited potent antitumor activity in vivo.
更多查看译文
关键词
phosphoroxy quinazoline derivatives,inhibitors,potential egfrt790m/c797s,synthesis
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要